|
Iris Oifigiúil |
GA Sraith C |
|
C/2023/1562 |
29.12.2023 |
Achoimre ar chinntí an Aontais Eorpaigh maidir le húdaruithe margaíochta i ndáil le táirgí íocshláinte ó 1 Samhain 2023 go dtí 30 Samhain 2023
(Arna fhoilsiú de bhun Airteagal 13 nó Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle (1) nó Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle (2))
(C/2023/1562)
— Údarú margaíochta a eisiúint (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
ANI (an tAinm Neamhdhílseánaigh Idirnáisiúnta) |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Foirm chógaisíochta |
An Cód CAT (an Cód Ceimiceach Teiripeach Anatamaíoch) |
Dáta an fhógra |
||
|
3.11.2023 |
Ninlaro |
ixazomib |
|
EU/1/16/1094 |
Capsúl, crua |
L01XG03 |
6.11.2023 |
||
|
6.11.2023 |
VANFLYTA |
quizartinib |
|
EU/1/23/1768 |
Piolla brataithe le scannán |
L01EX11 |
7.11.2023 |
||
|
15.11.2023 |
AQUMELDI |
enealapral mailéáite |
|
EU/1/23/1717 |
Orodispersible tablet |
C09AA02 |
16.11.2023 |
||
|
15.11.2023 |
Catiolanze |
N/A |
|
EU/1/23/1763 |
Eye drops, emulsion |
S01EE01 |
16.11.2023 |
||
|
15.11.2023 |
Dovprela |
pretomanid |
|
EU/1/20/1437 |
Taibléad |
J04AK08 |
16.11.2023 |
||
|
15.11.2023 |
Finlee |
dabrafenib |
|
EU/1/23/1767 |
Dispersible tablet |
L01EC02 |
16.11.2023 |
||
|
15.11.2023 |
Herwenda |
trastuzumab |
|
EU/1/23/1762 |
Púdar do thiúchán do thuaslagán le haghaidh insilte |
L01FD01 |
16.11.2023 |
||
|
16.11.2023 |
Ebglyss |
lebrikizumab |
|
EU/1/23/1765 |
Tuaslagán le haghaidh insteallta |
Pending |
17.11.2023 |
||
|
17.11.2023 |
Yorvipath |
palopegteriparatide |
|
EU/1/23/1766 |
Tuaslagán le haghaidh insteallta |
H05AA05 |
20.11.2023 |
— Údarú margaíochta a mhodhnú (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
3.11.2023 |
Copalia HCT |
|
EU/1/09/575 |
6.11.2023 |
||
|
3.11.2023 |
Exforge HCT |
|
EU/1/09/569 |
6.11.2023 |
||
|
3.11.2023 |
Jorveza |
|
EU/1/17/1254 |
6.11.2023 |
||
|
3.11.2023 |
Lutetium (177Lu) chloride Billev |
|
EU/1/22/1680 |
6.11.2023 |
||
|
3.11.2023 |
NeoRecormon |
|
EU/1/97/031 |
6.11.2023 |
||
|
3.11.2023 |
Rizmoic |
|
EU/1/18/1291 |
6.11.2023 |
||
|
3.11.2023 |
Tremelimumab AstraZeneca |
|
EU/1/22/1712 |
6.11.2023 |
||
|
6.11.2023 |
AJOVY |
|
EU/1/19/1358 |
10.11.2023 |
||
|
6.11.2023 |
Copalia |
|
EU/1/06/372 |
8.11.2023 |
||
|
6.11.2023 |
Dafiro |
|
EU/1/06/371 |
8.11.2023 |
||
|
6.11.2023 |
IDELVION |
|
EU/1/16/1095 |
9.11.2023 |
||
|
6.11.2023 |
Silodosin Recordati |
|
EU/1/18/1343 |
8.11.2023 |
||
|
6.11.2023 |
Xolair |
|
EU/1/05/319 |
8.11.2023 |
||
|
6.11.2023 |
Zirabev |
|
EU/1/18/1344 |
7.11.2023 |
||
|
15.11.2023 |
Brukinsa |
|
EU/1/21/1576 |
16.11.2023 |
||
|
15.11.2023 |
Carmustine medac |
|
EU/1/18/1278 |
16.11.2023 |
||
|
15.11.2023 |
Dafiro HCT |
|
EU/1/09/574 |
16.11.2023 |
||
|
15.11.2023 |
Daxas |
|
EU/1/10/636 |
16.11.2023 |
||
|
15.11.2023 |
Evra |
|
EU/1/02/223 |
20.11.2023 |
||
|
15.11.2023 |
Exforge |
|
EU/1/06/370 |
16.11.2023 |
||
|
15.11.2023 |
Fuzeon |
|
EU/1/03/252 |
16.11.2023 |
||
|
15.11.2023 |
Harvoni |
|
EU/1/14/958 |
16.11.2023 |
||
|
15.11.2023 |
Imfinzi |
|
EU/1/18/1322 |
16.11.2023 |
||
|
15.11.2023 |
Kivexa |
|
EU/1/04/298 |
16.11.2023 |
||
|
15.11.2023 |
Miglustat Dipharma |
|
EU/1/18/1346 |
16.11.2023 |
||
|
15.11.2023 |
Ocaliva |
|
EU/1/16/1139 |
22.11.2023 |
||
|
15.11.2023 |
Praluent |
|
EU/1/15/1031 |
16.11.2023 |
||
|
15.11.2023 |
PREVYMIS |
|
EU/1/17/1245 |
16.11.2023 |
||
|
15.11.2023 |
PREZISTA |
|
EU/1/06/380 |
16.11.2023 |
||
|
15.11.2023 |
Prometax |
|
EU/1/98/092 |
16.11.2023 |
||
|
15.11.2023 |
Rezolsta |
|
EU/1/14/967 |
16.11.2023 |
||
|
15.11.2023 |
Rilutek |
|
EU/1/96/010 |
16.11.2023 |
||
|
15.11.2023 |
Rubraca |
|
EU/1/17/1250 |
20.11.2023 |
||
|
15.11.2023 |
Stelara |
|
EU/1/08/494 |
16.11.2023 |
||
|
15.11.2023 |
Sustiva |
|
EU/1/99/110 |
20.11.2023 |
||
|
15.11.2023 |
TAKHZYRO |
|
EU/1/18/1340 |
17.11.2023 |
||
|
15.11.2023 |
Tecartus |
|
EU/1/20/1492 |
16.11.2023 |
||
|
15.11.2023 |
Triumeq |
|
EU/1/14/940 |
16.11.2023 |
||
|
15.11.2023 |
Trizivir |
|
EU/1/00/156 |
16.11.2023 |
||
|
15.11.2023 |
Vafseo |
|
EU/1/23/1725 |
30.11.2023 |
||
|
15.11.2023 |
VEYVONDI |
|
EU/1/18/1298 |
16.11.2023 |
||
|
15.11.2023 |
Vyvgart |
|
EU/1/22/1674 |
16.11.2023 |
||
|
15.11.2023 |
Xaluprine |
|
EU/1/11/727 |
16.11.2023 |
||
|
15.11.2023 |
Yuflyma |
|
EU/1/20/1513 |
20.11.2023 |
||
|
15.11.2023 |
Zynlonta |
|
EU/1/22/1695 |
17.11.2023 |
||
|
20.11.2023 |
Descovy |
|
EU/1/16/1099 |
22.11.2023 |
||
|
20.11.2023 |
Intelence |
|
EU/1/08/468 |
21.11.2023 |
||
|
20.11.2023 |
Kalydeco |
|
EU/1/12/782 |
21.11.2023 |
||
|
20.11.2023 |
Lumykras |
|
EU/1/21/1603 |
21.11.2023 |
||
|
20.11.2023 |
Orgovyx |
|
EU/1/22/1642 |
21.11.2023 |
||
|
20.11.2023 |
Paxlovid |
|
EU/1/22/1625 |
21.11.2023 |
||
|
20.11.2023 |
Pelmeg |
|
EU/1/18/1328 |
21.11.2023 |
||
|
20.11.2023 |
Pirfenidone Viatris |
|
EU/1/22/1707 |
21.11.2023 |
||
|
20.11.2023 |
Roteas |
|
EU/1/16/1152 |
22.11.2023 |
||
|
20.11.2023 |
Sirturo |
|
EU/1/13/901 |
21.11.2023 |
||
|
20.11.2023 |
Ziagen |
|
EU/1/99/112 |
21.11.2023 |
||
|
22.11.2023 |
Kaftrio |
|
EU/1/20/1468 |
23.11.2023 |
||
|
23.11.2023 |
Cufence |
|
EU/1/19/1365 |
27.11.2023 |
||
|
23.11.2023 |
KEYTRUDA |
|
EU/1/15/1024 |
24.11.2023 |
||
|
23.11.2023 |
PHEBURANE |
|
EU/1/13/822 |
24.11.2023 |
||
|
29.11.2023 |
Betaferon |
|
EU/1/95/003 |
30.11.2023 |
||
|
29.11.2023 |
Comirnaty |
|
EU/1/20/1528 |
30.11.2023 |
||
|
29.11.2023 |
Eviplera |
|
EU/1/11/737 |
1.12.2023 |
||
|
29.11.2023 |
Extavia |
|
EU/1/08/454 |
7.12.2023 |
||
|
29.11.2023 |
Lixiana |
|
EU/1/15/993 |
30.11.2023 |
||
|
29.11.2023 |
NYXTHRACIS |
|
EU/1/20/1485 |
30.11.2023 |
||
|
29.11.2023 |
Posaconazole Accord |
|
EU/1/19/1379 |
30.11.2023 |
||
|
29.11.2023 |
Resolor |
|
EU/1/09/581 |
1.12.2023 |
||
|
29.11.2023 |
Tabrecta |
|
EU/1/22/1650 |
4.12.2023 |
||
|
29.11.2023 |
Taxotere |
|
EU/1/95/002 |
1.12.2023 |
||
|
29.11.2023 |
Xermelo |
|
EU/1/17/1224 |
4.12.2023 |
||
|
29.11.2023 |
Yesafili |
|
EU/1/23/1751 |
30.11.2023 |
— Údarú margaíochta a tharraingt siar (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle)
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
6.11.2023 |
Tremelimumab AstraZeneca |
|
EU/1/22/1712 |
7.11.2023 |
— Údarú margaíochta a eisiúint (Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle; Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
ANI (an tAinm Neamhdhílseánaigh Idirnáisiúnta) |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Foirm chógaisíochta |
An Cód CAT (an Cód Ceimiceach Teiripeach Anatamaíoch) |
Dáta an fhógra |
||
|
20.11.2023 |
Nobivac LoVo L4 |
Vacsaín leptospira chainíneach |
|
EU/2/23/304 |
Fuaidreán le haghaidh insteallta |
QI07AB01 |
21.11.2023 |
||
|
20.11.2023 |
Senvelgo |
Velagliflozin |
|
EU/2/23/305 |
Oral solution |
QA10BK90 |
22.11.2023 |
||
|
23.11.2023 |
Bovilis Cryptium |
Cryptosporidium parvum Gp40 |
|
EU/2/23/303 |
Eibleacht le haghaidh insteallta |
QI02AO02 |
24.11.2023 |
— Údarú margaíochta a mhodhnú (Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle; Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
3.11.2023 |
Felisecto Plus |
|
EU/2/19/238 |
7.11.2023 |
||
|
20.11.2023 |
Tulinovet |
|
EU/2/20/257 |
21.11.2023 |
||
|
23.11.2023 |
CircoMax |
|
EU/2/21/281 |
24.11.2023 |
||
|
23.11.2023 |
FORTEKOR PLUS |
|
EU/2/15/185 |
24.11.2023 |
||
|
23.11.2023 |
Porcilis PCV ID |
|
EU/2/15/187 |
24.11.2023 |
||
|
23.11.2023 |
Suiseng Diff/A |
|
EU/2/21/278 |
27.11.2023 |
||
|
23.11.2023 |
Suvaxyn CSF Marker |
|
EU/2/14/179 |
27.11.2023 |
||
|
30.11.2023 |
Exzolt |
|
EU/2/17/212 |
4.12.2023 |
||
|
30.11.2023 |
Isemid |
|
EU/2/18/232 |
1.12.2023 |
||
|
30.11.2023 |
Kriptazen |
|
EU/2/18/234 |
1.12.2023 |
||
|
30.11.2023 |
Veraflox |
|
EU/2/10/107 |
1.12.2023 |
— Údarú margaíochta a tharraingt siar (Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle; Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle)
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
20.11.2023 |
Activyl |
|
EU/2/10/118 |
23.11.2023 |
Aon duine ar mian leis féachaint ar an tuarascáil mheasúnaithe phoiblí maidir leis na táirgí íocshláinte atá i gceist agus na cinntí a bhaineann léi, iarrtar orthu teagmháil a dhéanamh le:
|
European Medicines Agency |
|
Domenico Scarlattilaan 6 |
|
1083 HS Amsterdam |
|
NETHERLANDS |
ELI: http://data.europa.eu/eli/C/2023/1562/oj
ISSN 1977-107X (electronic edition)